1. Home
  2. ARCT

as 01-17-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 487.0M IPO Year: N/A
Target Price: $65.00 AVG Volume (30 days): 400.9K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.33 EPS Growth: N/A
52 Week Low/High: $14.30 - $45.00 Next Earning Date: 03-06-2025
Revenue: $160,399,000 Revenue Growth: -45.85%
Revenue Growth (this year): 7.33% Revenue Growth (next year): 4.71%

ARCT Daily Stock ML Predictions

Share on Social Networks: